At the same time, the brain uptake also showed a drastic decrease (p < 0.01) (Figure 4D), indicating the successful blockade of SV2A-specific uptake and the SV2A-specific binding of 18F-SynVesT-1 in the NCI-H660 tumor. This evidence concerns the gene SV2A and neoplasm.